| Medical Developments International Limited (MVP) ORDINARY FULLY PAID |
Health Care |
$52 |
Director Appointment and Resignation
|
30 May 2025 9:10AM |
$0.650 |
$0.460 |
fallen by
29.23%
|
|
| NICO Resources Limited (NC1) ORDINARY FULLY PAID |
Materials |
$26 |
Trading Halt
|
30 May 2025 9:09AM |
$0.073 |
$0.190 |
risen by
160.27%
|
|
NC1 - Price-sensitive ASX Announcement
Full Release
Key Points
- NICO Resources Limited (ASX: NC1) requested a trading halt on 11 March 2024.
- The trading halt is pending the release of an announcement regarding a capital raising.
- The trading halt will remain in place until either the company releases the announcement or until the start of trading on 13 March 2024.
- The purpose of the trading halt is to keep the market informed and prevent trading on an uninformed basis.
- The company’s securities will not be traded during the halt period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Latrobe Magnesium Limited (LMG) ORDINARY FULLY PAID |
Materials |
$59 |
Notification of cessation of securities - LMG
|
30 May 2025 9:09AM |
$0.011 |
$0.019 |
risen by
80.95%
|
|
| Cann Group Limited (CAN) ORDINARY FULLY PAID |
Health Care |
$9 |
CEO EGM Presentation
|
30 May 2025 9:08AM |
$0.014 |
$0.006 |
fallen by
60.71%
|
|
CAN - Price-sensitive ASX Announcement
Full Release
Key Points
- Overview of Cann Group Limited’s operations and medicinal cannabis focus
- Update on the proposed acquisition by Sun Pharma
- Operational highlights at the Mildura production facility
- Advancements in product pipeline and international market expansion
- Financial performance and position, including revenue growth and cost management
- Strategic priorities for future growth and value creation
- Discussion of risks, opportunities, and shareholder considerations regarding the acquisition
- Commitment to pharmaceutical-grade standards and product innovation
- Anticipated benefits of the acquisition for shareholders and business outlook
- Governance and leadership updates relevant to the Extraordinary General Meeting
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Immuron Limited (IMC) ORDINARY FULLY PAID |
Health Care |
$9 |
Notice under section 708A
|
30 May 2025 9:06AM |
$0.072 |
$0.029 |
fallen by
59.72%
|
|
| FFI Holdings Limited (FFI) ORDINARY FULLY PAID |
Consumer Staple |
$63 |
Expected Increase in Property Values
|
30 May 2025 9:06AM |
$3.610 |
$4.620 |
risen by
27.98%
|
|
FFI - Price-sensitive ASX Announcement
Full Release
Key Points
- FFI Holdings Limited received a recent independent valuation of its Welshpool property.
- The property value is expected to increase by approximately $12.5 million.
- The revaluation will be reflected in the financial statements for the year ending 30 June 2024.
- The increase will be recognized in the asset revaluation reserve on the balance sheet.
- There are no immediate cash flow or material profit and loss implications.
- The company is complying with accounting standards and continuous disclosure obligations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cavalier Resources Limited (CVR) ORDINARY FULLY PAID |
Materials |
$27 |
Raptor Completes Technical Due Diligence
|
30 May 2025 9:05AM |
$0.270 |
$0.375 |
risen by
38.89%
|
|
CVR - Price-sensitive ASX Announcement
Full Release
Key Points
- Raptor Capital International Limited completed technical due diligence on Cavalier Resources' gold projects.
- The assessment focused on the Crawford Gold Project and included a review of geological and operational data.
- The positive outcome of the due diligence is a prerequisite for executing a gold royalty agreement.
- The royalty agreement is intended to provide non-dilutive funding for the Crawford Gold Project.
- This development supports Cavalier Resources’ strategy to advance its gold assets.
- The announcement is dated 6 June 2024.
- Cavalier Resources aims to deliver value to shareholders through this partnership.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Count Limited (CUP) ORDINARY FULLY PAID |
Industrials |
$241 |
Change of Director's Interest Notice
|
30 May 2025 9:03AM |
$0.810 |
$1.175 |
risen by
45.06%
|
|
| American West Metals Limited (AW1) ORDINARY FULLY PAID |
Materials |
$55 |
Invitation to Participate in Share Purchase Plan
|
30 May 2025 9:03AM |
$0.038 |
$0.055 |
risen by
44.74%
|
|
AW1 - Price-sensitive ASX Announcement
Full Release
Key Points
- American West Metals Limited (AW1) announces a Share Purchase Plan (SPP) for eligible shareholders.
- The SPP aims to raise up to $2 million, with the company reserving the right to accept oversubscriptions.
- Eligible shareholders can purchase new fully paid ordinary shares at $0.16 per share, free of brokerage or transaction costs.
- The SPP is open to shareholders recorded as of 7:00pm (AEDT) on 18 March 2024 and residing in Australia or New Zealand.
- The funds raised will be used for exploration and development of the Storm Copper Project (Canada), West Desert Project (Utah, USA), and for general working capital.
- The SPP follows a recently completed institutional placement which raised $3.2 million.
- Application for the SPP closes at 5:00pm (AWST) on 8 April 2024, with allotment of new shares scheduled for 15 April 2024.
- The document details terms, eligibility, application processes, and relevant risks associated with the SPP.
- Directors who are eligible intend to participate in the SPP.
- The SPP offer is not underwritten and participation is voluntary.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Amotiv Limited (AOV) ORDINARY FULLY PAID |
Consumer Discretionary |
$871 |
Update - Notification of buy-back - AOV
|
30 May 2025 9:03AM |
$7.970 |
$6.510 |
fallen by
18.32%
|
|
| Aguia Resources Limited (AGR) ORDINARY FULLY PAID |
Materials |
$48 |
Share Purchase Plan Cleansing Notice
|
30 May 2025 9:02AM |
$0.039 |
$0.024 |
fallen by
38.46%
|
|
| Immuron Limited (IMC) ORDINARY FULLY PAID |
Health Care |
$9 |
Application for quotation of securities - IMC
|
30 May 2025 9:01AM |
$0.072 |
$0.029 |
fallen by
59.72%
|
|
| PYC Therapeutics Limited (PYC) ORDINARY FULLY PAID |
Health Care |
$1,298 |
Investor Webinar Presentation
|
30 May 2025 8:59AM |
$1.200 |
$1.320 |
risen by
10%
|
|
| Tigers Realm Coal Limited (TIG) ORDINARY FULLY PAID |
Materials |
$39 |
Notice of Annual General Meeting
|
30 May 2025 8:57AM |
$0.003 |
$0.003 |
fallen by
0%
|
|
| nanollose Limited (NC6) ORDINARY FULLY PAID |
Health Care |
$29 |
Andrew Moullin Appointed as MD/CEO
|
30 May 2025 8:56AM |
$0.047 |
$0.082 |
risen by
74.47%
|
|
NC6 - Price-sensitive ASX Announcement
Full Release
Key Points
- Andrew Moullin appointed as Managing Director and CEO of Nanollose Limited.
- Mr. Moullin brings significant expertise in biotechnology and renewable materials.
- His prior leadership roles and strategic vision are viewed as beneficial for Nanollose's next phase.
- Focus on advancing and commercializing Nanollose’s NC6 technology.
- Appointment aligns with company’s goal to accelerate growth in sustainable biomaterials.
- Strengthening of executive team to support commercialization and strategic objectives.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Findi Limited (FND) ORDINARY FULLY PAID |
Financials |
$57 |
FND FY25 Results Presentation
|
30 May 2025 8:55AM |
$5.050 |
$0.895 |
fallen by
82.28%
|
|
FND - Price-sensitive ASX Announcement
Full Release
Key Points
- Findi Limited (FND) reported its FY25 results in a presentation.
- The company continues to expand its digital financial services in India, particularly through its partnership with India Post Payments Bank (IPPB).
- Findi highlights record transaction volumes and growth in revenue, driven by increased demand for digital banking and financial inclusion initiatives.
- The company invests in technology upgrades, infrastructure, and expansion of service offerings to sustain long-term growth.
- FND’s business model focuses on rural and semi-urban markets, aiming to bridge the financial accessibility gap.
- Strong financial performance is reported, with double-digit growth in revenue and EBITDA.
- The presentation outlines strategic priorities, including leveraging regulatory changes and focusing on customer acquisition.
- FND reports high customer satisfaction and retention, aided by ongoing innovation and operational improvements.
- The outlook for the coming year remains positive, with the company targeting expansion into new geographies and additional services.
- Key risks identified include regulatory changes, competition, and challenges in scaling technology.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pacific Edge Limited (PEB) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Health Care |
$153 |
Trading Halt
|
30 May 2025 8:55AM |
$0.075 |
$0.150 |
risen by
100%
|
|
PEB - Price-sensitive ASX Announcement
Full Release
Key Points
- Pacific Edge Limited (PEB) requested a trading halt on 24 April 2024.
- The trading halt was initiated pending an announcement regarding a material development.
- The company is listed on the NZX and ASX exchanges.
- The trading halt is expected to last until the earlier of an announcement or market open on 26 April 2024.
- The company is a provider of diagnostic tests for bladder cancer.
- Pacific Edge Limited will be making an important announcement that could affect its share price.
- The halt was requested to ensure the market remains fully informed.
- Further details of the material development were not disclosed at the time of the trading halt.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Latrobe Magnesium Limited (LMG) ORDINARY FULLY PAID |
Materials |
$59 |
May Company Update
|
30 May 2025 8:55AM |
$0.011 |
$0.019 |
risen by
80.95%
|
|
| Coast Entertainment Holdings Limited (CEH) ORDINARY FULLY PAID |
Consumer Discretionary |
$175 |
Update - Notification of buy-back - CEH
|
30 May 2025 8:54AM |
$0.410 |
$0.450 |
risen by
9.76%
|
|
| Nuchev Limited (NUC) ORDINARY FULLY PAID |
Consumer Staple |
$22 |
Notification of cessation of securities - NUC
|
30 May 2025 8:52AM |
$0.190 |
$0.140 |
fallen by
26.32%
|
|
| NZME Limited (NZM) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Communication Services |
$169 |
Capital Change Notice - Performance Share Rights
|
30 May 2025 8:52AM |
$1.065 |
$0.900 |
fallen by
15.49%
|
|
| NZME Limited (NZM) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Communication Services |
$169 |
Capital Change Notice - Performance Share Rights
|
30 May 2025 8:51AM |
$1.065 |
$0.900 |
fallen by
15.49%
|
|
| Cadence Opportunities Fund Limited (CDO) ORDINARY FULLY PAID |
Financials |
$33 |
Update - Notification of buy-back - CDO
|
30 May 2025 8:51AM |
$1.610 |
$2.130 |
risen by
32.30%
|
|
| NZME Limited (NZM) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Communication Services |
$169 |
Capital Change Notice - Performance Share Rights
|
30 May 2025 8:51AM |
$1.065 |
$0.900 |
fallen by
15.49%
|
|
| NZME Limited (NZM) ORDINARY FULLY PAID FOREIGN EXEMPT NZX |
Communication Services |
$169 |
Capital Change Notice - Performance Share Rights
|
30 May 2025 8:50AM |
$1.065 |
$0.900 |
fallen by
15.49%
|
|
Call 1300 880 160
Start a chat
Schedule a call
